Search details
1.
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 25(3): 233-243.e8, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38105153
2.
Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report.
JTO Clin Res Rep
; 4(2): 100456, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36798785
3.
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.
Lung Cancer
; 178: 116-122, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36812760
4.
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.
Thromb Res
; 232: 133-137, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37976733
5.
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations.
Eur J Cancer
; 167: 142-148, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35307254
6.
Neoadjuvant treatment of stage IIIA-N2 in EGFR-Mutant/ALK-rearranged non-small cell lung cancer.
Transl Lung Cancer Res
; 10(1): 607-621, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33569340
7.
A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC.
Cancers (Basel)
; 13(21)2021 Nov 06.
Article
in English
| MEDLINE | ID: mdl-34771728
8.
Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie study.
Lung Cancer
; 155: 114-119, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33798900
9.
Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practice.
J Thorac Dis
; 13(3): 1658-1670, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33841957
10.
Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations.
World J Clin Oncol
; 12(11): 1047-1063, 2021 Nov 24.
Article
in English
| MEDLINE | ID: mdl-34909399
11.
EBUS-TBNA Cytological Samples for Comprehensive Molecular Testing in Non-Small Cell Lung Cancer.
Cancers (Basel)
; 13(9)2021 Apr 25.
Article
in English
| MEDLINE | ID: mdl-33923116
12.
Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer.
Mol Oncol
; 15(2): 350-363, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33236532
13.
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.
Eur J Cancer
; 150: 190-202, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33932726
14.
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.
J Immunother Cancer
; 9(3)2021 03.
Article
in English
| MEDLINE | ID: mdl-33753569
15.
In Search of the Long-Desired 'Copernican Therapeutic Revolution' in Small-Cell Lung Cancer.
Drugs
; 80(3): 241-262, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31912414
16.
Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients.
Diagnostics (Basel)
; 10(11)2020 Nov 03.
Article
in English
| MEDLINE | ID: mdl-33153192
17.
Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients.
Cancers (Basel)
; 12(5)2020 Apr 30.
Article
in English
| MEDLINE | ID: mdl-32365867
18.
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.
Cancers (Basel)
; 12(7)2020 Jul 08.
Article
in English
| MEDLINE | ID: mdl-32650523
19.
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.
Cancer Discov
; 2020 Jul 31.
Article
in English
| MEDLINE | ID: mdl-32737082
20.
PD-L1 expression testing in non-small cell lung cancer.
Ther Adv Med Oncol
; 10: 1758835918763493, 2018.
Article
in English
| MEDLINE | ID: mdl-29662547